Liver cell models are a valuable tool for studying NASH/NAFLD, but can be challenging to culture long-term. In this joint webinar, we break down the facts about the existing liver cell models, from 2D monolayer of hepatocytes to 3D co-culture models. We will share experience using 3D liver co-culture models for drug efficacy and safety assessments, along with information on assays used to interrogate the models. We will demonstrate why measuring multiple markers, including viability, cytotoxicity, and triglyceride levels, provides more relevant and predictive results for drug discovery efforts.
Michael Valley, PhD
Senior Research Scientist
Sue Grepper, PhD
Senior Application Scientist, InSphero
We love to talk science.
Sign up to receive monthly invitations to our webinars.